Summit Therapeutics Plc

Biotechnology Research

Focusing on improving patient outcomes for serious unmet medical needs.

Summit was founded in 2003 and their shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). They are headquartered in Menlo Park, California, and they have additional offices in Milton Park, Oxfordshire and Cambridge, UK